Tianyang Hu

726 total citations
42 papers, 465 citations indexed

About

Tianyang Hu is a scholar working on Epidemiology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Tianyang Hu has authored 42 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 11 papers in Surgery and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Tianyang Hu's work include Sepsis Diagnosis and Treatment (16 papers), Acute Kidney Injury Research (5 papers) and Hemodynamic Monitoring and Therapy (5 papers). Tianyang Hu is often cited by papers focused on Sepsis Diagnosis and Treatment (16 papers), Acute Kidney Injury Research (5 papers) and Hemodynamic Monitoring and Therapy (5 papers). Tianyang Hu collaborates with scholars based in China, United States and United Kingdom. Tianyang Hu's co-authors include Zhengwei Zhang, Guo‐Chao Zhong, Yang Peng, Fa‐Bao Hao, Jie‐Jun Hu, Lun Wan, Haitao Gu, Kang Wang, Liang Wang and Yanan Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Scientific Reports.

In The Last Decade

Tianyang Hu

41 papers receiving 459 citations

Peers

Tianyang Hu

EPIDE

SURGE

EDM

NEPHR

PHEOH

Won Jai Jung South Korea

John C. L. Wang United States

Ivan Jakopčić Croatia

José I. Gómez-Herreras Spain

Letícia Schwerz Weinert Brazil

Abhinav Gupta India

Konstantinos Leivaditis Greece

Danilo Fliser Germany

R. Lyu United States

João Victor Salgado Brazil

Won Jai Jung South Korea

Tianyang Hu

162 ×1.2

EPIDE

100 ×1.0

SURGE

40 ×0.4

EDM

65 ×0.7

NEPHR

41 ×0.5

PHEOH

Citations per year, relative to Tianyang Hu Tianyang Hu (= 1×) peers Won Jai Jung

Countries citing papers authored by Tianyang Hu

Since Specialization

Citations

This map shows the geographic impact of Tianyang Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianyang Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianyang Hu more than expected).

Fields of papers citing papers by Tianyang Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianyang Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianyang Hu. The network helps show where Tianyang Hu may publish in the future.

Co-authorship network of co-authors of Tianyang Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Tianyang Hu. A scholar is included among the top collaborators of Tianyang Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianyang Hu. Tianyang Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cao, Yu, Qirong Xie, Jingping Zhang, et al.. (2025). Macrophage HM13/SPP Enhances Foamy Macrophage Formation and Atherogenesis. Advanced Science. 12(18). e2412498–e2412498. 1 indexed citations

Wang, Xin, Xuerong Cui, Huaping Fan, & Tianyang Hu. (2024). Elevated Triglyceride-Glucose (TyG) Index Predicts Poor Clinical Outcomes in Critically Ill AECOPD Patients: A Retrospective Study. International Journal of COPD. Volume 19. 2217–2228. 4 indexed citations

Zhou, Yu‐Feng, et al.. (2024). Effect of proton pump inhibitors versus histamine‐2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 44(7). 539–548. 1 indexed citations

Chen, Qian, et al.. (2024). Dexmedetomidine administration is associated with improved outcomes in critically ill patients with acute myocardial infarction partly through its anti-inflammatory activity. Frontiers in Pharmacology. 15. 1428210–1428210. 3 indexed citations

Cai, Min, Yue Deng, & Tianyang Hu. (2024). Prognostic Value of Leukocyte-Based Risk Model for Acute Kidney Injury Prediction in Critically Ill Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients. International Journal of COPD. Volume 19. 619–632. 2 indexed citations

Li, Qiaoqiao, et al.. (2024). DENND5B Gene Expression as a Trigger for the Development of Diabetes Mellitus&#8211;Peripheral Artery Disease: Insights from a Univariate and Multivariate Mendelian Randomization Study. Global Heart. 19(1). 91–91.

Gao, Hongli, et al.. (2023). Insulin-like growth factor binding protein 2: a core biomarker of left ventricular dysfunction in dilated cardiomyopathy. Hereditas. 160(1). 36–36. 2 indexed citations

Li, Yingrui, Min Zhu, Yuqian Ren, et al.. (2023). Associations of starchy and non-starchy vegetables with risk of metabolic syndrome: evidence from the NHANES 1999–2018. Nutrition & Metabolism. 20(1). 36–36. 9 indexed citations

Hu, Tianyang, et al.. (2023). Sacubitril–valsartan versus enalapril for the treatment of acute decompensated heart failure in Chinese settings: A cost-effectiveness analysis. Frontiers in Pharmacology. 14. 925375–925375. 1 indexed citations

10.

Hu, Tianyang, et al.. (2023). Interaction of acute heart failure and acute kidney injury on in-hospital mortality of critically ill patients with sepsis: A retrospective observational study. PLoS ONE. 18(3). e0282842–e0282842. 2 indexed citations

11.

Hu, Tianyang & Rongzhong Huang. (2023). Urine output for predicting in-hospital mortality of intensive care patients with cardiogenic shock. Heliyon. 9(6). e16295–e16295. 2 indexed citations

12.

Gong, Rongpeng, et al.. (2022). Using optimal subset regression to identify factors associated with insulin resistance and construct predictive models in the US adult population. Endocrine Connections. 11(7). 2 indexed citations

13.

Hu, Tianyang, et al.. (2022). Cost-Effectiveness of Adding Empagliflozin to Standard Treatment for Heart Failure with Preserved Ejection Fraction Patients in China. American Journal of Cardiovascular Drugs. 23(1). 47–57. 12 indexed citations

14.

Hu, Tianyang, et al.. (2021). The association between four scoring systems and 30-day mortality among intensive care patients with sepsis: a cohort study. Scientific Reports. 11(1). 11214–11214. 23 indexed citations

15.

Ding, Chao & Tianyang Hu. (2021). Development and External Verification of a Nomogram for Patients with Persistent Acute Kidney Injury in the Intensive Care Unit. International Journal of General Medicine. Volume 14. 5005–5015. 9 indexed citations

16.

Hu, Tianyang, et al.. (2021). Albumin corrected anion gap for predicting in-hospital mortality among intensive care patients with sepsis: A retrospective propensity score matching analysis. Clinica Chimica Acta. 521. 272–277. 52 indexed citations

17.

Wang, Liang, Zhengwei Zhang, & Tianyang Hu. (2021). Effectiveness of LODS, OASIS, and SAPS II to predict in-hospital mortality for intensive care patients with ST elevation myocardial infarction. Scientific Reports. 11(1). 23887–23887. 19 indexed citations

18.

Zhang, Zhengwei, et al.. (2021). Association of Lymphocyte to Monocyte Ratio and Risk of in-Hospital Mortality in Patients with Cardiogenic Shock: A Propensity Score Matching Study. International Journal of General Medicine. Volume 14. 4459–4468. 9 indexed citations

19.

Zhong, Guo‐Chao, Haitao Gu, Yang Peng, et al.. (2021). Association of ultra-processed food consumption with cardiovascular mortality in the US population: long-term results from a large prospective multicenter study. International Journal of Behavioral Nutrition and Physical Activity. 18(1). 21–21. 65 indexed citations

20.

Hu, Tianyang, et al.. (2018). MicroRNA-421 inhibits caspase-10 expression and promotes breast cancer progression. Neoplasma. 65(1). 49–54. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact